3-Chloro-N-(4-sulfamoylphenyl)propanamide

Catalog No.: 
ACISHF359
CAS No.: 
104246-29-9
Molecular Formula: 
C9H11ClN2O3S
Molecular Weight: 
262.72
3-Chloro-N-(4-sulfamoylphenyl)propanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$81.00InquiryInquiry
1g95%$258.00InquiryInquiry
5g95%$1277.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-N-(4-sulfamoylphenyl)propanamide
IUPAC Name3-chloro-N-(4-sulfamoylphenyl)propanamide
MDL No.MFCD03383381
Molecular FormulaC9H11ClN2O3S
Molecular Weight262.72
SMILESO=C(NC1=CC=C(S(=O)(N)=O)C=C1)CCCl
InChI KeyWKWALIXZDKXXKC-UHFFFAOYSA-N
SynonymN-[4-(AMINOSULFONYL)PHENYL]-3-CHLOROPROPANAMIDE;3-Chloro-N-(4-sulfaMoylphenyl)propanaMide;3-chloro-N-(4-sulfamoylphenyl)propionamide;4-(3-chloropropanoylamino)benzenesulfonamide;Propanamide, N-[4-(aminosulfonyl)phenyl]-3-chloro-
CAS No.104246-29-9

Synthetic Route by SureRoute

1. ACISHF359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKIP713 route compound structure diagram
    ACYKIP7136101-31-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACISHF359 route product structure diagram
    ACISHF359104246-29-9
Inquiry

2. ACISHF359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKIP713 route compound structure diagram
    ACYKIP7136101-31-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACISHF359 route product structure diagram
    ACISHF359104246-29-9
Inquiry

3. ACISHF359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKIP713 route compound structure diagram
    ACYKIP7136101-31-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACISHF359 route product structure diagram
    ACISHF359104246-29-9
Inquiry

Comments (0)